FDA Approves Durvalumab Plus Chemo for Biliary Tract Cancer ...Middle East

Medscape - News
The immune checkpoint inhibitor is already approved for use in lung cancer. Now it is also approved for use in combination with chemotherapy for locally advanced or metastatic biliary tract cancer. FDA Approvals

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves Durvalumab Plus Chemo for Biliary Tract Cancer )

Apple Storegoogle play

Also on site :